The UK’s Medicines and Healthcare products Regulatory Agency, the MHRA, would welcome more clinical trials being performed in the UK, in the interest of promoting a research culture for the benefit of clinicians and patients.
The UK was once renowned as the toughest competent authority when it came to clinical trials, though it was sometimes criticised for the length of time it took to deal with clinical trials applications...
Please login to read the full article.
